Have a personal or library account? Click to login
Utilization of Gonadotropin-Releasing Hormone Agonists in the Treatment of Metastatic and Locally Advanced Prostate Cancer - Comparisons of Practices from Three European Countries Cover

Utilization of Gonadotropin-Releasing Hormone Agonists in the Treatment of Metastatic and Locally Advanced Prostate Cancer - Comparisons of Practices from Three European Countries

EABR. Experimental and Applied Biomedical Research
Volume 26 (2025): Issue 2 (June 2025)
By: Ivan Milovanovic,  Filip Milutinovic,  Djordje Djordjevic,  Filip Mihajlovic,  Vladimir Bancevic and  Dragan Milovanovic  
Open Access
|Dec 2025
DOI: https://doi.org/10.2478/sjecr-2021-0070 | Journal eISSN: 2956-2090 | Journal ISSN: 2956-0454
Journal RSS Feed
Language: English
Page range: 189 - 196
Submitted on: Nov 8, 2021
|
Accepted on: Dec 27, 2021
|
Published on: Dec 31, 2025
Published by: University of Kragujevac, Faculty of Medical Sciences
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
prostatic neoplasms,
LHRH agonists,
ATC/DDD metholology,
drug utilization
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2025 Ivan Milovanovic, Filip Milutinovic, Djordje Djordjevic, Filip Mihajlovic, Vladimir Bancevic, Dragan Milovanovic, published by University of Kragujevac, Faculty of Medical Sciences
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous articleVolume 26 (2025): Issue 2 (June 2025)Next article